Younger Individuals May Have the Highest Risk of Presenting with Distant-stage Colorectal Cancer
Risk may be greatest among young Black and Hispanic subgroups PHILADELPHIA – Individuals between 20 and 39 years old...
Risk may be greatest among young Black and Hispanic subgroups PHILADELPHIA – Individuals between 20 and 39 years old...
Findings have implications for future cancer clinical trial design involving immune checkpoint inhibitors PHILADELPHIA – Independent drug action, not...
Study reports progressive improvement in the outcomes of patients carrying the Philadelphia chromosome PHILADELPHIA – For patients with acute...
Resource reflects transition from a mostly microscopy-driven to a molecularly driven classification system PHILADELPHIA – The first classification of...
Next-generation sequencing for minimal residual disease was highly sensitive and more accurate than flow cytometry and monitoring of B-cell...
PHILADELPHIA – A diet involving short-term, severe calorie restriction was safe, feasible, and resulted in a decrease of blood...
PHILADELPHIA – Patients with advanced renal cell carcinoma who received the checkpoint inhibitor combination nivolumab (Opdivo) plus ipilimumab (Yervoy)...
PHILADELPHIA – Younger B-cell non-Hodgkin lymphoma (B-NHL) survivors had a higher relative risk of developing age-related diseases than older...
PHILADELPHIA — The American Association for Cancer Research (AACR) today announced the opening of the submission site for its...
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the appointment of Massimo Loda, MD, as the...